Bone morphogenetic protein 2 (BMP-2) belongs to the TGF - β superfamily of proteins and is a multifunctional ligand protein that has the ability to induce undifferentiated mesenchymal stem cells to differentiate and proliferate towards chondrocytes and osteoblasts, thereby promoting bone formation.
Overview of Market Development
The global BMP-2 market shows a stable growth trend, and the future development prospects are promising. According to our research data, the estimated revenue scale of the global BMP-2 market in 2024 is $574 million, an increase of 5.10% compared to 2023, and is expected to continue to increase to $800 million by 2029. The CAGR for 2024-2029 is estimated to be 6.87%.
Market Analysis of Major Regions
From a regional perspective, the global BMP-2 market is dominated by North America. Data shows that the revenue share of the North American BMP-2 market is expected to reach 84.86% in 2024; The Asia Pacific and European markets are expected to rank second and third with shares of 10.69% and 4.22%, respectively.
Global Bone Morphogenetic Protein(BMP) 2 Market Revenue and Market Share by Region Forecast
Source: www.globalmarketmonitor.com
Analysis of Downstream Application Pattern
From the perspective of downstream application patterns, BMP-2 is widely used in fields such as spinal fusion surgery, hip/knee replacement surgery, long bone fractures, ankle fractures, trauma surgery, and oral and maxillofacial surgery. Among them, trauma surgery accounts for the highest share, estimated at 20.23% in 2024; Next is the field of spinal fusion surgery, accounting for 19.87%.
Global Bone Morphogenetic Protein(BMP) 2 Market Revenue and Market Share by Region Forecast
|
Applications
|
Market Revenue (Million USD)
|
Market Share
|
|
Spinal Fusion Surgery
|
114.07
|
19.87%
|
|
Hip/Knee Replacement Surgery
|
53.00
|
9.23%
|
|
Long Bone Fractures
|
83.24
|
14.50%
|
|
Ankle Fractures
|
60.53
|
10.54%
|
|
Trauma Surgery
|
116.16
|
20.23%
|
|
Oral And Maxillofacial Surgery
|
79.16
|
13.79%
|
|
Others
|
67.96
|
11.84%
|
Source: www.globalmarketmonitor.com
Chinese